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Effect of Vitamin E, Vitamin C, and &Carotene on Stroke Risk 
In a recent prospective observational stud% vita- 
mins C and E and B-carotene did not elicit protec- 
tive effects on stroke risk. Lutein, however, may 
elicit such protection. Nevertheless, these nutri- 
ents may be important modulators of the outcome 
after the occurrence of a stroke. At present, opti- 
mal control of the classic stroke risk factors in 
combination with increased consumption of fruits, 
vegetables, and antioxidant nutrients may repre- 
sent the safest and most efficient strategy to con- 
trol stroke risk. 
Stroke mortality is the third leading cause of death in the 
United States,'.* after cardiovascular diseases and cancer. 
Although the pathogeneses of these three leading causes 
of death may be very different, they share several risk 
factors. Present evidence suggests that reactive oxygen 
species such as superoxide anions or singlet oxygen may 
play an important role in the pathogenesis of all three, 
including affecting the outcome of the different forms of 
stroke.*5 For example, vitamin E may reduce the risk of 
atherosclerotic heart disease through its inhibitory effects 
on low-density lipoprotein cholesterol oxidation, platelet 
function, or enthothelial function.' Atherosclerotic dis- 
ease processes are similar in vascular beds other than the 
coronary arteries, and thus it is plausible that vitamin E 
alone or in combination with other antioxidant nutrients 
may play a role in the pathogenesis of stroke. 
A recent study by Ascherio et a1.6 examined the ef- 
fects ofvitamin E, vitamin C, and carotenoids (p-carotene 
and lutein) on ischemic stroke risk in the cohort of the 
Health Professionals Follow-up Study. In this prospec- 
tive observational study, more than 43,000 subjects were 
observed during an 8-year follow-up period. The study 
participants were all men ages 40 to 75 who did not have 
cardiovascular disease or diabetes mellitus. Dietary in- 
take was assessed by a self-administered food frequency 
questionnaire. During the observation period, 328 strokes 
(21 0 ischemic, 70 hemorrhagic, and 48 unclassified) oc- 
curred. Vitamin E and vitamin C intake (independently, 
whether from diet or supplements) had no significant ef- 
fect on overall stroke risk (independent of the type of 
stroke). The relative risk (RR) for ischemic stroke in the 
top quintile of vitamin C intake (with a median intake of 
1 167 mg/day) by comparison with the bottom quintile (me- 
dian intake of 95 mg/day) was 1.03 (confidence interval 
[CI], 0.66-1.59, nonsignificant). The analysis ofthe RR for 
total stroke in relation to vitamin C intake was similar. 
This review was prepared by Paolo M. Suter, M.D., 
M.S., Medical Policlinic, University Hospital, 8091 
Zurich, Switzerland. 
The age-adjusted RR for ischemic stroke in the top 
quintile ofvitamin E intake (41 1 international units [IU]/ 
day) compared with the bottom quintile of vitamin E in- 
take (5.4 N/day) was 1.18 (95% CI, 0.77-1.82; P> 0.2 for 
trend). The effects of this vitamin on the RR for total stroke 
were similar.6 Hemorrhagic stroke risk was slightly higher 
in the top quintiles of vitamin E intake, although this ef- 
fect did not reach the level of significance (RR = 1.3 1 ; CI, 
Interestingly, p-carotene and lutein intakes were in- 
versely related to the risk of ischemic as well as total stroke, 
although multivariate analysis did attenuate the signifi- 
cance of p-carotene's effect on stroke risk! The intake of 
lutein was associated with a marginally significant reduc- 
tion of ischemic stroke risk (RR = 0.63; CI, 0.4-0.99; P = 0.1 
for trend). The reduction of the effect of carotenoids on 
stroke risk in this study may be caused by the colinearity 
of carotenoids with other nutrients. 
Some earlier studies reported a protective effect of 
vitamin C on stroke r i ~ k , ~ J  whereas other studies did not 
find a protective effect of vitamin C.9-" The differential 
effects of vitamin C may be due to other population char- 
acteristics, which may be of importance as stroke risk fac- 
tors and may remain uninfluenced by vitamin C (e.g., ge- 
netic background). This is also supported by the results 
of a prospective study from Shanghai in which no signifi- 
cant association was found between vitamin C and vita- 
min E intake.1° Additionally, in the large supplementation 
trial from Linxian, no effect of vitamin C supplements was 
seen on stroke risk.12 Although the two Chinese studies 
were done in rather different regions, some stroke risk 
factors may prevail without influence by the nutrients of 
interest in the present review. 
The relationship between vitamin E nutriture and 
stroke risk seems to be less controversial. A large Finnish 
trial reported an increased risk of stroke with vitamin E 
supplementation (RR = 1 .5).13 Even though in the Linxian 
Trial a similar dose of vitamin E was given, no significant 
effect on stroke risk was seen.12 These two studies are, 
however, very different regarding baseline nutriture as 
well as other baseline conditions, so they cannot be com- 
pared. Nevertheless, it can be concluded that in these 
older studies vitamin E was not associated with a protec- 
tive effect on the risk of stroke. Similarly, in the study by 
Ascherio et a1.,6 the risk for hemorrhagic stroke was slightly 
higher in the top quintile ofvitamin E intake (RR = 1.3 1 ; CI, 
0.62-2.76). The median vitamin E intake in the top quintile 
was 4 1 1 IU/day compared with 5.4 IU/day in the bottom 
quintile. This can be explained by the effect of vitamin E 
on vitamin K metaboli~m,'~- '~ which elicits an anticoagula- 
tory effect and a higher bleeding tendency. Despite these 
known pharmacologic effects of vitamin E on vitamin K, 
0.62-2.76). 
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the effect on hemorrhagic stroke risk is not surprising, 
and the lack of significance may be explained by the rela- 
tively low mean and median intake of vitamin E in the top 
quintile of intakes, in which 93% ofthe subjects were tak- 
ing supplements. In contrast, in the Alpha-Tocopherol 
Beta-Carotene Cancer Prevention Study, even with a-to- 
copherol supplementation of 50 IU/day a significant in- 
crease in hemorrhagic stroke risk was found.I3 These data 
illustrate nicely that each single nutrient alone or in com- 
bination may have favorable as well as unfavorable ef- 
fects. 
Accordingly, the indication for supplementation of 
certain nutrients should be formulated very carefully. Al- 
though there is no conclusive prospective evidence for 
the role of vitamin E in the prevention of cardiovascular 
disease, vitamin E supplement doses of 100-400 IU/day 
are recommended.s This amount may be much too high for 
certain subjects owing to an increase in bleeding tendency, 
which can be further increased by the ingestion of war- 
farin and/or acetylsalicylic acid.16 
Studies regarding the association between caro- 
tenoids and stroke risk are rare. Two studies reported an 
increased risk for stroke upon p-carotene supplementa- 
tion.I3,l7 The data are controversial and no conclusion re- 
garding the effect of p-carotene can be made. There are 
several hundreds of carotenoids found in nature, and it is 
conceivable that some of them may have protective ef- 
fects, whereas others may have deleterious effects. In the 
present study, lutein seems to have a protective effect on 
stroke risk. Some of the major sources of lutein are dark- 
green leafy vegetables. 
In an earlier study, Ascherio et al.ls reported an in- 
verse association between the risk of stroke and the in- 
take of potassium, magnesium, and cereal fiber. This is in 
agreement with the suggestion that carotenoid and lutein 
nutriture are indicators of a healthy diet, rich in h i t s  and 
vegetables that are the principal sources of potassium, 
fiber, and vitamin C.I9 The latter observation also sup- 
ports the concept that the overall diet has a more signifi- 
cant effect on risk reduction than any one single nutrient. 
This agrees with current recommendations to ingest an 
overall balanced diet that is rich in h i t s  and vegetablesZo 
as well as the diet fits all” concept,2’ which promotes 
such a diet during all periods of life, from the “cradle to the 
grave.” 
There are innumerable studies reporting protective ef- 
fects of a diet rich in vegetables and h i t s  for most diseases, 
including cardiovascular disease and cancer.22-2s In view of 
the complex mixture of nutrients and protective agents (i.e., 
phytochemicals) in fmts and vegetables, it is impossible to 
identi@ a single “miracle” nutrient for protection f?om certain 
diseases. It is most likely the “natural” mix of chemicals that 
elicits protection, and present evidence suggests that this 
natural mix of chemicals is more important than any one nutri- 
ent that can be added to the diet in the form of a supplement. 
The recommendation to obtain the essential nutri- 
ents (e.g., the Recommended Daily Allowance) from the 
diet whenever possible is also reflected in the findings 
from Ascherio et a1.6 in that neither the dose nor the dura- 
tion of vitamin E and/or vitamin C supplement intake fa- 
vorably affected total or ischemic stroke risk. Although 
certain people require specific recommendations (e.g., 
children, women, some elderly), the formulation of general 
recommendations that are understandable, easy to follow, 
and feasible is important. The concept of a diet that fits all 
individuals is very attractive and is probably the most 
promising for disease prevention in the long run?’ Present 
evidence suggests that there is no single miracle nutrient 
for the prevention and/or treatment of chronic diseases; 
individuals with healthy lifestyles that include a healthful 
diet, however, stand a greater chance of reaping these 
benefits. 
The results of the present study6 are in agreement 
with earlier which reported conflicting results 
regarding the protective effects of these nutrients on stroke 
risk. As the authors point out,6 different studies cannot be 
compared owing to miscellaneous limitations such as the 
prevalence of malnutrition or various supplement intakes. 
Accordingly, the intake of certain nutrients represents 
more of an indicator of risk than specific risk factors. In 
the study by Ascherio et a1.,6 the significant association 
between stroke risk and lutein as well as p-carotene is 
probably a proxy for a high intake of h i t s  and vegetables. 
The potential preventive effects of single nutrients 
vary fiom one study to the next owing to factors such as 
overall diet, lifestyle, age, baseline nutritional status, and 
study duration (i.e., length of follow-up). This is illus- 
trated by the lack of a relationship between vitamin C in- 
take and stroke risk in the present study.6 The intake of 
vitamin C in this population varied widely and tended to 
be more than the present recommendation, even in the 
bottom quintile. Another recent studys reported a strong 
negative relationship between biochemical vitamin C sta- 
tus and dietary intake of vitamin C and the risk of stroke 
during a follow-up period of 20 years in elderly subjects 
(ages > 65 years). In the study by Ascherio et a1.,6 the 
participants’ age range was 40-75 years, and the duration 
of follow-up was only 8 years. These factors related to the 
study design may be important modulators of the out- 
come, especially in relation to chronic diseases. 
The present study6 is of great public health impor- 
tance because stroke-related morbidity and mortality are 
of primary concern to the public. The negative results of 
this study are not at all disappointing, but rather under- 
line the complexity of the disease entity that is summa- 
rized as stroke. Stroke represents a group of different dis- 
eases with varying pathophysiologic bases.2J6 Different 
modifiable risk factors for stroke have been identified and 
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the control of these risk factors will reduce the risk of 
stroke considerably.2 To conclude from the data of 
Ascherio et a1.6 that vitamins do not play an important role 
in reducing stroke risk may be very wrong. When consid- 
ering disease risk, one must consider the pathogenesis, 
progression, therapy, and final outcome. 
Overall nutrition as well as single nutrients may af- 
fect the different stages of the disease process differently. 
There are several lines of experimental and observational 
evidence suggesting that an adequate supply of the vita- 
mins discussed in this article may result in an improved 
outcome after the occurrence of a stroke.4~~2'-~~ Animal 
studies have reported an outcome in different stroke mod- 
els that depends upon nutritional factors.30 Ischemia in 
general, especially cerebral ischemia, followed by 
reperfusion (and thus reoxygenation) induces increased 
free radical production and injury that is not directly re- 
lated to the initial hypoxia. This phenomenon is called 
reoxygenation injury, and vitamin E has been shown to 
reduce such reoxygenation injury after hypoxia, owing to 
a lowering of free radical damage.3' Accordingly, the size 
of the infarct is larger in vitamin E-deficient animals by 
comparison with animals with better vitamin E nutriture. 
In stroke patients, lower vitamin E and carotenoid levels, 
as well as lipid peroxidation markers, have been described. 
At present, however, it is not known whether such changes 
in antioxidant status are the cause or the consequence of 
the cerebrovascular event. 
In several studies, a reduction in stroke and overall 
cardiovascular risk was associated with increased con- 
sumption of h i t s  and  vegetable^.'^,^^-^^ Additionally, in 
intervention studies,35 a decrease in stroke risk upon 
supplementation with vitamins and/or trace elements has 
been reported. One recent supplementation trial in Linxian 
reported a stroke risk reduction of 55% (RR = 0.45, P < 
0.05).3s Another study reported that subjects with low 
baseline serum selenium levels showed a higher stroke 
mortality during a follow-up period of 9 years.36 In agree- 
ment with these observations, stroke patients showed 
lower antioxidant vitamin levels as well as increased bio- 
chemical lipid peroxidation parameters within 24 hours of 
the clinical event! The controversial findings from experi- 
mental and epidemiologic studies could be explained by 
the fact that stroke is a very heterogeneous disease. Fur- 
thermore, the occurrence of a clinical event may impose 
acute overall stress including metabolic stress with an 
increased requirement for antioxidative nutrients so that 
short-term alterations of different biochemical parameters 
(nutrients as well as peroxidation parameters) may occur, 
although they are not directly related to the pathogen- 
esis. 
From the present evidence it can be said that the clas- 
sical risk factors2 are of more importance than nutritional 
factors in the pathogenesis of stroke. Nevertheless, the 
classical risk factors can be modulated by nutritional fac- 
tors such that if a stroke occurs, the outcome may be 
better in a patient with a better overall nutriture. 
There is no single cause or risk factor for stroke. Hy- 
pertension probably represents the most consistent risk 
factor, and stroke is mainly caused by insufficient control 
of this classical risk factor?J6 Undertreatment of hyper- 
tension has been identified as one of the leading causes 
of excess stroke mortality and morbidity in hypertensive 
subjects?' In view of the scale of stroke morbidity and 
mortality, the search for stroke risk factors will and has to 
go on. At present, optimal control of the classical stroke 
risk factors combined with increased consumption of fruits, 
vegetables, and antioxidant nutrients may represent the 
safest and most efficient strategy to control stroke risk. 
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